Frequency Therapeutics, Inc. Contracts & Agreements
62 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (4)
- Human Resources (23)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (5)
- Uncategorized (11)
- Employment Agreement, dated November 9, 2023, by and between Korro Bio, Inc. and Todd Chappell (Filed With SEC on December 1, 2023)
- Employment Agreement, dated November 8, 2023, by and between Korro Bio, Inc. and Steve Colletti (Filed With SEC on December 1, 2023)
- Employment Agreement, dated November 8, 2023, by and between Korro Bio, Inc. and Shelby Walker (Filed With SEC on December 1, 2023)
- Korro Bio, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on December 1, 2023)
- Korro Bio, Inc. 2023 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on December 1, 2023)
- Employment Agreement, dated as of November 8, 2023, by and between Korro Bio, Inc. and Vineet Agarwal (Filed With SEC on November 14, 2023)
- Employment Agreement, dated as of November 10, 2023, by and between Korro Bio, Inc. and Ram Aiyar, Ph.D (Filed With SEC on November 14, 2023)
- Form of Indemnification Agreement for Officers of Korro Bio, Inc (Filed With SEC on November 6, 2023)
- Subscription Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto (Filed With SEC on November 6, 2023)
- Registration Rights Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto (Filed With SEC on November 6, 2023)
- Form of Lock-Up Agreement (Filed With SEC on November 6, 2023)
- Contingent Value Rights Agreement dated November 3, 2023 (Filed With SEC on November 6, 2023)
- Form of Indemnification Agreement for Directors of Korro Bio, Inc (Filed With SEC on November 6, 2023)
- Korro Bio, Inc. 2023 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on November 6, 2023)
- Korro Bio, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on November 6, 2023)
- Korro Bio, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 6, 2023)
- Korro Bio, Inc. Senior Executive Cash Incentive Bonus Plan (Filed With SEC on November 6, 2023)
- Warrant Agreement dated January 22, 2021 (Filed With SEC on November 6, 2023)
- Korro Bio, Inc. 2019 Stock Incentive Plan, and form of award agreements thereunder (Filed With SEC on November 6, 2023)
- Separation Agreement, dated as of July 28, 2023, by and between Frequency Therapeutics, Inc. and Christopher Loose (Filed With SEC on July 31, 2023)
- Form of Lock-Up Agreement by and between Korro Bio, Inc. and directors and officers of Frequency Therapeutics, Inc (Filed With SEC on July 14, 2023)
- Agreement and Plan of Merger, dated July 14, 2023, by and among Frequency Therapeutics, Inc., Frequency Merger Sub, Inc., and Korro Bio, Inc (Filed With SEC on July 14, 2023)
- Form of Support Agreement by and between Frequency Therapeutics, Inc. and certain stockholders of Korro Bio, Inc (Filed With SEC on July 14, 2023)
- Form of Support Agreement by and between Korro Bio, Inc. and certain stockholders of Frequency Therapeutics, Inc (Filed With SEC on July 14, 2023)
- Form of Lock-Up Agreement by and between Korro Bio, Inc. and directors, officers and certain stockholders of Korro Bio, Inc (Filed With SEC on July 14, 2023)
- Form of CVR Agreement (Filed With SEC on July 14, 2023)
- Amendment to Letter Agreement by and between Frequency Therapeutics, Inc. and Richard Mitrano, dated June 1, 2023 (Filed With SEC on June 6, 2023)
- Separation Agreement by and between Frequency Therapeutics, Inc. and Wendy Arnold, dated February 17, 2023 (Filed With SEC on May 12, 2023)
- Separation Agreement by and between Frequency Therapeutics, Inc. and Carl LeBel, dated March 23, 2023 (Filed With SEC on March 29, 2023)
- Sublease Agreement, dated July 8, 2022, by and between Frequency Therapeutics, Inc. and Saliogen Therapeutics, Inc (Filed With SEC on July 12, 2022)
- Employment Agreement, dated as of November 25, 2020, by and between Frequency Therapeutics, Inc. and Quentin McCubbin (Filed With SEC on May 4, 2022)
- Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Wendy Arnold (Filed With SEC on April 15, 2022)
- Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Richard Mitrano (Filed With SEC on April 15, 2022)
- Separation Agreement, dated as of March 31, 2022, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh (Filed With SEC on March 31, 2022)
- Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and Frequency Therapeutics, Inc (Filed With SEC on March 15, 2022)
- Equity Distribution Agreement, dated as of December 10, 2021, between Frequency Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on December 10, 2021)
- Employment Agreement, effective February 3, 2020, by and between Frequency Therapeutics, Inc. and Wendy S. Arnold (Filed With SEC on March 29, 2021)
- Agreement for Termination of Lease and Voluntary Surrender of Premises, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and ARE-MA-Region No. 20, LLC (Filed With SEC on December 16, 2020)
- Loan and Security Agreement, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on December 15, 2020)
- Employment Agreement, effective December 1, 2020, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh (Filed With SEC on December 1, 2020)
- Registration Rights Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein (Filed With SEC on July 21, 2020)
- Securities Purchase Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein (Filed With SEC on July 21, 2020)
- Description of Frequency Therapeutics, Inc. Securities (Filed With SEC on March 26, 2020)
- Lease Agreement, dated as of August 24, 2016, as amended, between ARE-MA Region No. 20 and Frequency Therapeutics, Inc (Filed With SEC on March 26, 2020)
- Indenture of Lease, effective as of January 7, 2020 between HCP/KING 75 Hayden LLC and Frequency Therapeutics, Inc (Filed With SEC on March 26, 2020)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 23, 2019)
- Form of Specimen Common Stock Certificate (Filed With SEC on September 23, 2019)
- 2019 Incentive Award Plan and form of option agreements thereunder (Filed With SEC on September 23, 2019)
- Non-Employee Director Compensation Program (Filed With SEC on September 23, 2019)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on September 23, 2019)
- Lease Agreement, effective as of August 1, 2019 between the University of Connecticut and the Registrant (Filed With SEC on September 23, 2019)
- Second Amended and Restated Executive Employment Agreement, dated as of September 20, 2019, between David L. Lucchino and the Registrant (Filed With SEC on September 23, 2019)
- Amended and Restated Employment Agreement, dated as of September 20, 2019, between Christopher R. Loose and the Registrant (Filed With SEC on September 23, 2019)
- Employment Agreement, dated as of September 19, 2019, between Carl P. LeBel and the Registrant (Filed With SEC on September 23, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 23, 2019)
- Second Amended and Restated Investors Rights Agreement, dated as of July 17, 2019, by and among the Registrant and the investors party thereto (Filed With SEC on September 6, 2019)
- 2014 Stock Incentive Plan, as amended, and form of option agreements thereunder (Filed With SEC on September 6, 2019)
- Form of Founder Restricted Stock Agreement (Filed With SEC on September 6, 2019)
- Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and the Registrant (Filed With SEC on September 6, 2019)
- Non-Exclusive Patent License Agreement, dated as of February 7, 2019, between Massachusetts Eye and Ear Infirmary and the Registrant (Filed With SEC on September 6, 2019)
- License and Collaboration Agreement, dated as of July 16, 2019, between Astellas Pharma, Inc. and the Registrant (Filed With SEC on September 6, 2019)
- Lease Agreement, dated as of August 24, 2016, between ARE-MA Region No. 20 and the Registrant (Filed With SEC on September 6, 2019)